Investigators uncovered that community oncology practices emerged as the preferred sites of service for cancer treatment compared with hospitals and academic centers, according to a recent case study. The findings may challenge the common perception of hospitals and academic centers as preferable cancer treatment sites and shed light on the significant advantages offered by community oncology practices in delivering high-quality cancer care.
Study Methods and Results
In the recent case study, the investigators evaluated the key factors influencing patient outcomes, cost-effectiveness, and overall satisfaction with cancer care delivery models.
The investigators discovered that community oncology practices outperformed hospitals and academic centers in several critical areas: personalized care, convenience and accessibility, cost-effectiveness, and collaborative approach. Community oncology practices also excelled in providing personalized treatment plans tailored to individual patient needs. With a patient-centered approach, these practices prioritized empathy, communication, and accessibility—fostering strong patient-provider relationships that were crucial for navigating the complexities of cancer care.
Additionally, the investigators found that patients receiving cancer care in a community oncology setting, often located close to their homes, experienced reduced travel times and related expenses as well as increased accessibility to care. They noted that patient proximity to care is often a large contributor to improved adherence to treatment regimens, directly impacting patient outcomes.
The investigators emphasized the cost-effectiveness of care delivery in community oncology settings. By avoiding the overhead expenses associated with large hospital systems and through close relationships with insurers, community oncology practices may offer competitive pricing without compromising the quality of care—thereby alleviating financial burdens on patients and payers alike. Further, community oncology practices promoted collaboration with hospitals and academic centers, leveraging shared expertise and resources to optimize patient outcomes. This collaborative environment allowed for innovation, knowledge exchange, and continuous improvement in cancer care delivery.
Conclusions
“The collective insights we reveal in this case study are poised to spark meaningful discussions among policymakers, health-care stakeholders, and the general public about the future of cancer care delivery,” underscored Nathan H. Walcker, MBA, Chief Executive Officer of the Florida Cancer Specialists & Research Institute. “By amplifying the voice of community oncology practices, the study advocates for a more inclusive, patient-centered health-care system that celebrates diversity and innovation,” he added.
“The findings summarized in this case study challenge the conventional wisdom surrounding cancer care delivery. Community oncology practices represent a cornerstone of comprehensive cancer care, offering a holistic approach that prioritizes patient well-being and clinical excellence,” concluded Lucio N. Gordan, MD, President and Managing Physician of the Florida Cancer Specialists & Research Institute.
